JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258676

Human SLC25A5 (Adenine Nucleotide Translocator 2/ANT 2) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SLC25A5 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 7 bp deletion in exon1 and Insertion of the selection cassette in exon1.

View Alternative Names

2F1, AAC2, ADP, ADP ATP carrier protein 2, ADP/ATP translocase 2, ADT2_HUMAN, ANT 2, ATP carrier protein, ATP carrier protein 2, Adenine nucleotide translocator 2, OTTHUMP00000024324, SLC25A5, Solute carrier family 25 (mitochondrial carrier adenine nucleotide translocator) member 5, Solute carrier family 25 member 5, T2, T3, fibroblast isoform

2 Images
Sanger Sequencing - Human SLC25A5 (Adenine Nucleotide Translocator 2/ANT 2) knockout HeLa cell lysate (AB258676)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC25A5 (Adenine Nucleotide Translocator 2/ANT 2) knockout HeLa cell lysate (AB258676)

Allele-1 : 7 bp deletion in exon1

Sanger Sequencing - Human SLC25A5 (Adenine Nucleotide Translocator 2/ANT 2) knockout HeLa cell lysate (AB258676)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC25A5 (Adenine Nucleotide Translocator 2/ANT 2) knockout HeLa cell lysate (AB258676)

Allele-2 : Insertion of the selection cassette in exon1

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 7 bp deletion in exon1 and Insertion of the selection cassette in exon1.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258676-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SLC25A5 knockout HeLa cell lysate", "number":"AB258676-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258676-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SLC25A5
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Adenine Nucleotide Translocator 2 (ANT 2) also referred to as ANT protein or 2 ANT is an important component of the mitochondrial inner membrane. It belongs to the family of adenine nucleotide translocator proteins with a molecular weight of about 33 kDa. ANT 2 facilitates the exchange of ATP and ADP across the mitochondrial membrane. This protein is mainly expressed in tissues with high energy demand such as the heart liver and skeletal muscle.
Biological function summary

ANT 2 functions to regulate cellular energy metabolism by controlling the exchange of adenine nucleotides between the mitochondria and cytosol. It is a part of the permeability transition pore complex which plays a role in maintaining mitochondrial membrane potential and preventing apoptosis. ANT 2 interacts with nucleotides to modulate energy production making it essential for the maintenance of cellular bioenergetics.

Pathways

ANT 2 integrates into significant energy production pathways including oxidative phosphorylation. It forms a functional unit with proteins like the voltage-dependent anion channel (VDAC) within the mitochondrial interface. This relationship with VDAC is key to ATP production and involves cellular energy transactions fundamental to numerous metabolic and signaling pathways.

ANT 2 demonstrates relevance to both cancer and cardiomyopathy. In cancer the overexpression of ANT 2 may support the high energy demands of rapidly proliferating cells. Meanwhile in cardiomyopathy mutations or dysregulation in ANT 2 impact energy metabolism leading to heart dysfunction. The interaction of ANT 2 with pro-apoptotic proteins like Bax influences the pathogenesis of these diseases by mediating mitochondrial-induced apoptosis.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com